Oral nystatin prophylaxis in surgical/trauma ICU patients: A randomised clinical trial

Critical Care

Volumn 16, Issue 2, 2012, Pages

  Giglio, Mariateresa ^a   Caggiano, Giuseppina ^a   Dalfino, Lidia ^a   Brienza, Nicola ^a   Alicino, Ilaria ^a   Sgobio, Aurelia ^a   Favale, Antonella ^a   Coretti, Caterina ^a   Montagna, Maria T ^a   Bruno, Francesco ^a   Puntillo, Filomena ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NYSTATIN; ANTIFUNGAL AGENT;

ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CHEMOPROPHYLAXIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; FEMALE; FUNGAL COLONIZATION; GASTROINTESTINAL PAIN; HOSPITALIZATION; HUMAN; INCIDENCE; INJURY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NAUSEA; NONHUMAN; PHARYNX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH; SURGICAL PATIENT; URTICARIA; VOMITING; CHI SQUARE DISTRIBUTION; INTENSIVE CARE; MIDDLE AGED; NONPARAMETRIC TEST; ORAL DRUG ADMINISTRATION; PROCEDURES; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTIFUNGAL AGENTS; CANDIDIASIS; CHI-SQUARE DISTRIBUTION; CRITICAL CARE; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NYSTATIN; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84860513021     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11300     Document Type: Article

References (34)

1. Arendrup M. Epidemiology of invasive candidiasis. Curr Opin Crit Care 2010, 16:445-452. 10.1097/MCC.0b013e32833e84d2, 20711075.
2. Olaechea PM, Palomar M, León-Gil C, Alvarez-Lerma F, Jordá R, Nolla-Salas J, León-Regidor MA, . EPCAN Study Group Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis 2004, 23:323-330. 10.1007/s10096-004-1104-x, 15024623, EPCAN Study Group.
3. Hassan I, Powell G, Sidhu M, Hart WM, Denning DW. Excess mortality, length of stay and cost attributable to candidaemia. J Infect 2009, 59:360-365. 10.1016/j.jinf.2009.08.020, 19744519.
4. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007, 20:133-163. 10.1128/CMR.00029-06, 1797637, 17223626.
5. Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, Biraghi E, Canton E, Zimmermann K, Seaton S, Grillot R, . ECMM Working Group on Candidaemia Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004, 23:317-322. 10.1007/s10096-004-1103-y, 15029512, ECMM Working Group on Candidaemia.
6. Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 2006, 27:359-366. 10.1016/j.ijantimicag.2006.01.002, 16647248.
7. Leleu G, Aegerter P, Guidet B. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care 2002, 17:168-175. 10.1053/jcrc.2002.35815, 12297992.
8. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1998, 148:2642-2645.
9. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994, 220:751-758. 10.1097/00000658-199412000-00008, 1234477, 7986142.
10. Vardakas KZ, Michalopoulos A, Kiriakidou KG, Siampli EP, Samonis G, Falagas ME. Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients. Clin Microbiol Infect 2009, 15:289-292. 10.1111/j.1469-0691.2008.02653.x, 19154488.
11. Voss A, Hollis RJ, Pfaller MA, Wenzel RP. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 1994, 32:975-980. 267165, 8027353.
12. Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut?. Clin Infect Dis 2001, 33:1959-1967. 10.1086/323759, 11702290.
13. León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, León MA, . EPCAN Study Group A bedside scoring system ('Candida score') for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006, 34:730-737. 10.1097/01.CCM.0000202208.37364.7D, 16505659, EPCAN Study Group.
14. Marchena-Gomez J, Saez-Guzman T, Hemmersbach-Miller M, Conde-Martel A, Morales-Leon V, Bordes-Benitez A, Acosta-Merida MA. Candida isolation in patients hospitalized on a surgical ward: significance and mortality-related factors. World J Surg 2009, 33:1822-1829. 10.1007/s00268-009-0120-5, 19551428.
15. Solomkin JS, Flohr AB, Quie PG, Simmons RL. The role of Candida in intraperitoneal infections. Surgery 1980, 88:524-530.
16. Normand S, François B, Dardé ML, Bouteille B, Bonnivard M, Preux PM, Gastinne H, Vignon P. Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients. Intensive Care Med 2005, 31:1508-1513. 10.1007/s00134-005-2807-x, 16195905.
17. Tortorano AM, Caspani L, Rigoni AL, Biraghi E, Sicignano A, Viviani MA. Candidosis in the intensive care unit: a 20-year survey. J Hosp Infect 2004, 57:8-13. 10.1016/j.jhin.2004.01.017, 15142710.
18. Caggiano G, Puntillo F, Coretti C, Giglio M, Alicino I, Manca F, Bruno F, Montagna MT. Candida colonization index in patients admitted to an ICU. Int J Mol Sci 2011, 12:7038-7047. 10.3390/ijms12107038, 3211025, 22072934.
19. Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2006, 26:271-276.
20. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005, 49:3640-3645. 10.1128/AAC.49.9.3640-3645.2005, 1195428, 16127033.
21. Schuster MG, Edwards JE, Sobel JD, Darouiche RO, Karchmer AW, Hadley S, Slotman G, Panzer H, Biswas P, Rex JH. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 2008, 149:83-90.
22. Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA. Double-blind placebo controlled trial of fluconazole to prevent Candidal infections in critically ill surgical patients. Ann Surg 2001, 233:542-548. 10.1097/00000658-200104000-00010, 1421284, 11303137.
23. Stypula WT, Kale-Pradan PB. Therapeutic dilemma of fluconazole prophylaxis in intensive care. Ann Pharmacother 2002, 36:155-159.
24. Rex JH, Sobel JD. Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 2001, 32:1191-1200. 10.1086/319763, 11283809.
25. Lam SW, Eschenauer GA, Carver PL. Evolving role of early antifungals in the adult intensive care unit. Crit Care Med 2009, 37:1580-1593. 10.1097/CCM.0b013e31819dec9b, 19325484.
26. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD, . Infectious Diseases Society of America Clinical practice guidelines for the management of invasive candidiasis: 2009 update by the Infectious Disease Society of America. Clin Infect Dis 2009, 48:503-535. 10.1086/596757, 19191635, Infectious Diseases Society of America.
27. Eggimann P, Wolff M, Garbino J. Oral nystatin as antifungal prophylaxisin critically ill patients: an old SDD tool to be renewed?. Intensive Care Med 2005, 31:1466-1468. 10.1007/s00134-005-2806-y, 16195906.
28. Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2006, 6:21. 10.1186/1471-2334-6-21, 1379648, 16472387.
29. Dubè MP, Heseltine PN, Rinaldi MG, Evans S, Zawacki B. Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Clin Infect Dis 1994, 18:77-82. 10.1093/clinids/18.1.77, 8054438.
30. Silvestri L, van Saene HK, Milanese M, Gregori D. Impact of selective decontamination of the digestive tract on fungal carriage and infection: systematic review of randomized controlled trials. Intensive Care Med 2005, 31:898-910. 10.1007/s00134-005-2654-9, 15895205.
31. Viale P. Candida colonization and candiduria in critically ill patients in the intensive care unit. Drugs 2009, 69(Suppl 1):51-57.
32. León C, Alvarez-Lerma F, Ruiz-Santana S, León MA, Nolla J, Jordá R, Saavedra P, Palomar M, . EPCAN Study Group Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis 2009, 28:233-242. 10.1007/s10096-008-0618-z, 18758831, EPCAN Study Group.
33. van de Veerdonk FL, Kullberg BJ, Netea MG. Pathogenesis of invasive candidiasis. Curr Opin Crit Care 16:453-459.
34. Ostrosky-Zeichner L. Prophylaxis and treatment of invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2004, 23:739-744. 10.1007/s10096-004-1215-4, 15372315.